USE OF EXTENDED-RELEASE PRAMIPEXOLE IN EARLY-STAGE PARKINSON’S DISEASE: DESCRIPTION OF A CLINICAL CASE

USE OF EXTENDED-RELEASE PRAMIPEXOLE IN EARLY-STAGE PARKINSON’S DISEASE: DESCRIPTION OF A CLINICAL CASE

Show other versions (1)

<p>The paper considers a clinical case of early-stage mixed Parkinson’s disease (PD) with significant affective disorders and restless legs syndrome. Once-daily extended-release pramipexole 3 mg significantly improved a patient’s status and led to regression of movement and affective disorders...

Full description

Bibliographic Details
Main Authors: N. V. Fedorova, Ye. N. Gubanova
Format: Article
Language:Russian
Published: ABV-press 2014-11-01
Series:Klinicist
Subjects:
dopamine receptor agonists
pramipexole
Parkinson’s disease
depression
Online Access:http://klinitsist.abvpress.ru/index.php/Klin/article/view/152

Internet

http://klinitsist.abvpress.ru/index.php/Klin/article/view/152

Similar Items